{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:02:11Z","timestamp":1790118131398,"version":"4.0.1"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"\n Background<\/jats:title>\n \n Malignant pleural mesothelioma (PM) is a highly aggressive thoracic malignancy with an extremely poor prognosis and limited effective therapeutic strategies, representing a critical unmet clinical need. Fanconi anemia complementation group D2 (FANCD2) is a critical effector of the cellular DNA damage response system and plays a central role in maintaining genomic integrity. While the genoprotective functions of\n FANCD2<\/jats:italic>\n have been extensively characterized, its specific biological roles and molecular regulatory mechanisms in the malignant progression of PM remain poorly understood. The current study aimed to evaluate FANCD2 expression and its clinical associations in PM and to examine the effects of transient FANCD2 knockdown in NCI-H2052 cells.\n <\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n Comprehensive bioinformatics analyses were performed based on public transcriptomic data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases to profile\n FANCD2<\/jats:italic>\n expression patterns and evaluate its clinical prognostic value in PM. Differential expression analysis was applied to confirm the aberrant upregulation of\n FANCD2<\/jats:italic>\n in PM tissues, and the associations of\n FANCD2<\/jats:italic>\n expression levels with tumor pathological staging and patient clinical prognosis were systematically assessed. Western blotting was further performed to evaluate the protein expression status of FANCD2 in clinical PM specimens and NCI-H2052 cells, with normal tissues and corresponding normal cells included as control groups. Transient\n FANCD2<\/jats:italic>\n knockdown was achieved in NCI-H2052 cells using two independent small interfering RNAs (siRNAs). A series of functional experiments were conducted to determine the effects of\n FANCD2<\/jats:italic>\n silencing on the proliferation, wound closure, and apoptosis of NCI-H2052 cells. For mechanistic exploration, the expression levels of core apoptotic proteins were detected to evaluate the association between\n FANCD2<\/jats:italic>\n depletion and Caspase\/PARP-related apoptotic signaling. In addition, tumor immune infiltration analysis was performed to investigate the correlation between FANCD2 expression and M2 macrophage infiltration within the PM tumor microenvironment (TME). FANCD2 rescue and Z-VAD-FMK inhibition experiments were performed to further evaluate the involvement of caspase-dependent apoptosis.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Bioinformatics results demonstrated that\n FANCD2<\/jats:italic>\n was significantly upregulated in PM tissues relative to normal control samples. Higher FANCD2 expression was associated with tumor T stage and unfavorable survival outcomes in the exploratory TCGA-MESO analysis. Consistently, Western blotting confirmed markedly increased FANCD2 protein levels in both clinical PM tissues and NCI-H2052 cells. Functional assays in NCI-H2052 cells revealed that siRNA-mediated\n FANCD2<\/jats:italic>\n knockdown significantly suppressed cell proliferation and reduced wound-closure capacity of NCI-H2052 cells, whereas it significantly increased apoptosis. Mechanistic investigations further found that\n FANCD2<\/jats:italic>\n silencing was associated with increased levels of caspase\/PARP-related apoptotic markers, as evidenced by the markedly enhanced protein levels of cleaved caspase-3, cleaved caspase-8, cleaved caspase-9, and cleaved PARP. FANCD2 restoration and pharmacological caspase inhibition partially reversed FANCD2 knockdown-induced growth suppression and apoptosis, further supporting the involvement of caspase-dependent apoptotic signaling. Moreover, TME immune correlation analysis indicated that high FANCD2 expression was positively associated with M2 macrophage infiltration in PM tumors. These findings represent exploratory correlations derived from computational immune-cell estimation.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n In summary, FANCD2 may contribute to PM progression by supporting malignant phenotypes and limiting apoptosis. FANCD2 restoration and caspase inhibition partially reversed the growth suppression and apoptosis induced by FANCD2 knockdown, supporting the involvement of caspase-dependent apoptotic signaling. In addition, FANCD2 expression was positively associated with the computationally estimated proportion of M2 macrophages, suggesting that FANCD2 may represent an exploratory prognostic marker and a candidate therapeutic target for further investigation in PM.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fgene.2026.1926600","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:10:33Z","timestamp":1790115033000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["FANCD2 knockdown suppresses malignant phenotypes and is associated with caspase\/PARP-mediated apoptosis in NCI-H2052 pleural mesothelioma cells"],"prefix":"10.3389","volume":"17","author":[{"given":"YingFang","family":"Xiang","sequence":"first","affiliation":[{"name":"College of Basic Medical Sciences, Health Science Center, Dali University","place":["Dali, Yunnan, China"]},{"name":"Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Dali University","place":["Dali, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Radiology, The People's Hospital of Lincang City","place":["Lincang, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RuiYing","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Basic Medical Sciences, Health Science Center, Dali University","place":["Dali, Yunnan, China"]},{"name":"Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&D, College of Pharmacy, Dali University","place":["Dali, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhao","sequence":"additional","affiliation":[{"name":"College of Basic Medical Sciences, Health Science Center, Dali University","place":["Dali, Yunnan, China"]},{"name":"Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&D, College of Pharmacy, Dali University","place":["Dali, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZhengLiang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiology, The First Affiliated Hospital of Dali University","place":["Dali, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WenZhong","family":"Yang","sequence":"additional","affiliation":[{"name":"College of Basic Medical Sciences, Health Science Center, Dali University","place":["Dali, Yunnan, China"]},{"name":"Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&D, College of Pharmacy, Dali University","place":["Dali, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ChangCheng","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The First Affiliated Hospital of Kunming Medical University","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HongYun","family":"Chen","sequence":"additional","affiliation":[{"name":"College of Basic Medical Sciences, Health Science Center, Dali University","place":["Dali, Yunnan, China"]},{"name":"College of Public Health, Dali University","place":["Dali, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The First Affiliated Hospital of Kunming Medical University","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[{"name":"College of Basic Medical Sciences, Health Science Center, Dali University","place":["Dali, Yunnan, China"]},{"name":"Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&D, College of Pharmacy, Dali University","place":["Dali, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e0304072","DOI":"10.1371\/journal.pone.0304072","article-title":"Achillea fragrantissima (Forssk.) Sch.Bip instigates the ROS\/FADD\/c-PARP expression that triggers apoptosis in breast cancer cell (MCF-7)","volume":"19","author":"Alasmari","year":"2024","journal-title":"PLoS One"},{"key":"B2","doi-asserted-by":"publisher","first-page":"107172","DOI":"10.1016\/j.lungcan.2023.03.008","article-title":"New pathogenic germline variants identified in mesothelioma","volume":"179","author":"Belcaid","year":"2023","journal-title":"Lung Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.3390\/cancers13164194","article-title":"Epidemiology and clinical aspects of malignant pleural mesothelioma","volume":"13","author":"Brims","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1136\/thoraxjnl-2018-212380","article-title":"Early specialist palliative care on quality of life for malignant pleural mesothelioma: a randomised controlled trial","volume":"74","author":"Brims","year":"2019","journal-title":"Thorax"},{"key":"B5","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3322\/caac.21572","article-title":"Mesothelioma: scientific clues for prevention, diagnosis, and therapy","volume":"69","author":"Carbone","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"B6","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"B7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: an update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia"},{"key":"B8","doi-asserted-by":"publisher","first-page":"eabf8495","DOI":"10.1126\/scitranslmed.abf8495","article-title":"Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancer","volume":"13","author":"Chuckran","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.trecan.2018.03.010","article-title":"B7-H3 in cancer-beyond immune regulation","volume":"4","author":"Flem-Karlsen","year":"2018","journal-title":"Trends Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","article-title":"The 2015 World Health Organization classification of tumors of the pleura: advances since the 2004 classification","volume":"11","author":"Galateau-Salle","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.3390\/cancers17233863","article-title":"Circulating biomarkers and targeted therapy in pleural mesothelioma","volume":"17","author":"Grant","year":"2025","journal-title":"Cancers"},{"key":"B12","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41419-021-03463-8","article-title":"p53 induces ARTS to promote mitochondrial apoptosis","volume":"12","author":"Hao","year":"2021","journal-title":"Cell Death Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"mjac074","DOI":"10.1093\/jmcb\/mjac074","article-title":"The ARTS of p53-dependent mitochondrial apoptosis","volume":"14","author":"Hao","year":"2023","journal-title":"J. Mol. Cell Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/17476348.2019.1568875","article-title":"Diagnosis of asbestos-related lung diseases","volume":"13","author":"Harris","year":"2019","journal-title":"Expert Rev. Respir. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1038\/s41416-022-01979-0","article-title":"Genomic landscape of pleural and peritoneal mesothelioma tumours","volume":"127","author":"Hiltbrunner","year":"2022","journal-title":"Br. J. Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s12885-024-12213-w","article-title":"ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation","volume":"24","author":"Huang","year":"2024","journal-title":"BMC Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1056\/NEJMra1912719","article-title":"Perspectives on the treatment of malignant pleural mesothelioma","volume":"385","author":"Janes","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092545","article-title":"FANCD2 confers a malignant phenotype in esophageal squamous cell carcinoma by regulating cell cycle progression","volume":"12","author":"Lei","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12885-023-10626-7","article-title":"FANCD2 inhibits ferroptosis by regulating the JAK2\/STAT3 pathway in osteosarcoma","volume":"23","author":"Li","year":"2023","journal-title":"BMC Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1042\/ebc20200001","article-title":"Structural insight into FANCI-FANCD2 monoubiquitination","volume":"64","author":"Li","year":"2020","journal-title":"Essays Biochem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1016\/j.cell.2024.03.039","article-title":"IGSF8 is an innate immune checkpoint and cancer immunotherapy target","volume":"187","author":"Li","year":"2024","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/s41590-020-0733-2","article-title":"Neuropilin-1 is a T cell memory checkpoint limiting long-term antitumor immunity","volume":"21","author":"Liu","year":"2020","journal-title":"Nat. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jss.2015.01.043","article-title":"Impact of mesothelioma histologic subtype on outcomes in the surveillance, epidemiology, and end results database","volume":"196","author":"Meyerhoff","year":"2015","journal-title":"J. Surg. Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12885-022-09314-9","article-title":"Comprehensive analysis of the autophagy-dependent ferroptosis-related gene FANCD2 in lung adenocarcinoma","volume":"22","author":"Miao","year":"2022","journal-title":"BMC Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/jb\/mvab034","article-title":"Sweet modification and regulation of death receptor signalling pathway","volume":"169","author":"Moriwaki","year":"2021","journal-title":"J. Biochem."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081804","article-title":"FANCD2 and DNA damage","volume":"18","author":"Nepal","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3389\/fimmu.2020.00784","article-title":"The tumor microenvironment in the response to immune checkpoint blockade therapies","volume":"11","author":"Petitprez","year":"2020","journal-title":"Front. Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"5284","DOI":"10.1002\/jcp.29414","article-title":"Data mining analysis of the PP2A cell cycle axis in mesothelioma patients","volume":"235","author":"Pippa","year":"2020","journal-title":"J. Cell Physiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.lungcan.2009.03.016","article-title":"Malignant pleural mesothelioma: genome-wide expression patterns reflecting general resistance mechanisms and a proposal of novel targets","volume":"67","author":"R\u00f8e","year":"2010","journal-title":"Lung Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1006\/excr.2000.4994","article-title":"Arrest of S-phase progression is impaired in Fanconi anemia cells","volume":"260","author":"Sala-Trepat","year":"2000","journal-title":"Exp. Cell Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e2025109","DOI":"10.1001\/jamanetworkopen.2020.25109","article-title":"Prevalence of high tumor mutational burden and association with survival in patients with less common solid tumors","volume":"3","author":"Shao","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"B32","doi-asserted-by":"publisher","first-page":"921963","DOI":"10.3389\/fphar.2022.921963","article-title":"Abnormally expressed ferroptosis-associated FANCD2 in mediating the temozolomide resistance and immune response in glioblastoma","volume":"13","author":"Song","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1372113","DOI":"10.3389\/fimmu.2024.1372113","article-title":"Novel prognostic biomarker TBC1D1 is associated with immunotherapy resistance in gliomas","volume":"15","author":"Song","year":"2024","journal-title":"Front. Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41419-026-08818-7","article-title":"BAP1 and USP1 cooperate to regulate FANCD2 stability and cell proliferation in mesothelioma cells","volume":"17","author":"Suzuki","year":"2026","journal-title":"Cell Death Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s40001-023-01411-0","article-title":"FANCD2 as a novel prognostic biomarker correlated with immune and drug therapy in hepatitis B-related hepatocellular carcinoma","volume":"28","author":"Tang","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10549-007-9534-7","article-title":"Loss of expression of FANCD2 protein in sporadic and hereditary breast cancer","volume":"107","author":"van der Groep","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"B38","doi-asserted-by":"publisher","first-page":"148498","DOI":"10.1016\/j.gene.2024.148498","article-title":"Identification of the ferroptosis-related prognostic gene signature in mesothelioma","volume":"919","author":"Wang","year":"2024","journal-title":"Gene"},{"key":"B39","first-page":"11101","article-title":"p53 mediated apoptosis in osteosarcoma MG-63 cells by inhibition of FANCD2 gene expression","volume":"8","author":"Xia","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"110762","DOI":"10.1016\/j.ygeno.2023.110762","article-title":"Pan-cancer analysis of the tumorigenic role of Fanconi anemia complementation group D2 (FANCD2) in human tumors","volume":"116","author":"Xie","year":"2024","journal-title":"Genomics"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/2211-5463.70056","article-title":"FEM1B enhances TRAIL-induced apoptosis in T lymphocytes and monocytes","volume":"15","author":"Yang","year":"2025","journal-title":"FEBS Open Bio"},{"key":"B42","doi-asserted-by":"publisher","first-page":"8837","DOI":"10.1038\/s41598-018-27106-9","article-title":"Cadmium-induced apoptosis in neuronal cells is mediated by Fas\/FasL-mediated mitochondrial apoptotic signaling pathway","volume":"8","author":"Yuan","year":"2018","journal-title":"Sci. Rep."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1111\/1759-7714.13393","article-title":"ANTP-SmacN7 fusion peptide-induced radiosensitization in A549 cells and its potential mechanisms","volume":"11","author":"Zhang","year":"2020","journal-title":"Thorac. Cancer"},{"key":"B44","doi-asserted-by":"publisher","first-page":"113388","DOI":"10.1016\/j.yexcr.2022.113388","article-title":"FANCD2 promotes the malignant behavior of endometrial cancer cells and its prognostic value","volume":"421","author":"Zheng","year":"2022","journal-title":"Exp. Cell Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/path.6245","article-title":"FANCD2 deficiency sensitizes SHH medulloblastoma to radiotherapy via ferroptosis","volume":"262","author":"Zhou","year":"2024","journal-title":"J. Pathol."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1926600\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:10:34Z","timestamp":1790115034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1926600\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":45,"alternative-id":["10.3389\/fgene.2026.1926600"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2026.1926600","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"article-number":"1926600"}}